Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GlaxoSmithKline (GSK) has stated that a Philadelphia judge entered judgment in favour of the company and dismissed a case alleging that use of Paxil during pregnancy caused 14-year-old Anna Blyth to be born with certain cardiac birth defects.
Subscribe to our email newsletter
GSK said that unfortunately, birth defects occur in three to five percent of all live births, whether or not the mother was taking medication during pregnancy.
GSK believes it acted properly and responsibly in researching and studying Paxil, including sharing documentation and submitting results from studies on Paxil to regulators.
GSK claimed that they also believe that once approved for use, the company acted properly in marketing the medicine, including monitoring its safety, updating pregnancy information in the medicine’s labeling as new information became available and communicating important safety information to regulatory agencies, the scientific and medical community and the public.